Islet cell failure in type 2 diabetes
Open accessThe DOI matches its Crossref record; 134 of the 134 references it cites were found in a registry or an index; none of the 272 sources its claims cite is checked for support yet.
Abstract
The major focus of this Review is on the mechanisms of islet beta cell failure in the pathogenesis of obesity-associated type 2 diabetes (T2D). As this demise occurs within the context of beta cell compensation for insulin resistance, consideration is also given to the mechanisms involved in the compensation process, including mechanisms for expansion of beta cell mass and for enhanced beta cell performance. The importance of genetic, intrauterine, and environmental factors in the determination of "susceptible" islets and overall risk for T2D is reviewed. The likely mechanisms of beta cell failure are discussed within the two broad categories: those with initiation and those with progression roles.
Overview
CoChat Summary
## TL;DR
This is a 2006 review arguing that type 2 diabetes develops when insulin-resistant islets can no longer sustain compensatory b cell function, leading first to dysfunction and then progressive loss of b cell mass. It emphasizes that “susceptible” islets are shaped by genetic, intrauterine, and environmental factors, and that hyperglycemia accelerates damage through glucotoxic and glucolipotoxic mechanisms.
## Key findings
- In longitudinal studies, insulin levels rise during the normoglycemic and prediabetes phases and then decline when fasting glycemia exceeds the upper normal limit of 5.5 mM, marking b cell failure.
- A longitudinal study in Pima Indians found that b cell dysfunction was the major determinant of progression from normoglycemia to diabetes.
- In autopsy pancreata from 124 subjects, the paper reports a 40% and 63% loss of islet b cell volume in obese subjects with impaired fasting glucose and T2D, respectively, compared with weight-matched controls; lean T2D subjects had a 41% loss versus lean controls.
- The paper reports that the STOP-NIDDM trial showed acarbose treatment of IGT subjects reduced the risk of progression to diabetes by 36%.
## Methods
- Narrative review of mechanistic, animal, human postmortem, genetic, and epidemiologic studies on islet b cell compensation and failure in obesity-associated T2D.
- Synthesizes findings from rodent models (including ZF, ZDF, DBA2, GK, and IUGR models) and human islet/pancreas studies, including a transcript profiling study of 7 normal and 5 T2D human islet samples.
- Main analysis is integrative and conceptual: it organizes evidence into mechanisms that promote compensation and mechanisms with initiation versus progression roles in b cell failure.
## Limitations
- The paper states that the mechanisms of b cell compensation are “not fully understood,” and that the role of several proposed factors remains to be established or warrants further investigation.
- It explicitly notes uncertainty about several mechanisms, including whether nonimmune islet inflammation contributes in vivo, whether IAPP is causal in b cell dysfunction and demise, and whether reduced ARNT expression is an early defect or a consequence.
- Evident from the text: this is a review, not a new experimental study, so its conclusions depend on the quality and consistency of the cited animal and human studies rather than on a single primary dataset.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 1 Not valid · 164 Not checked · 38 Own results and interpretations
In the paper
“Longitudinal studies of subjects that develop T2D show a rise in insulin levels in the normoglycemic and prediabetes phases that keep glycemia near normal despite the insulin resistance ( b cell compensation), followed by a decline when fasting glycemia surpasses the upper limit of normal of 5.5 mM ( b cell failure) (5) (Figure 1).”
What the sources say
- Not checked yetcites [5]
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“With respect to the latter, increases were observed in enzymes and metabolites involved in anaplerosis and the malate-pyruvate and citratepyruvate shuttles of ZF islets (12).”
What the sources say
- Not checked yetcites [12]
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Inhibition of these pathways by phenylacetic acid, which inhibits PC, markedly impeded GSIS (12).”
What the sources say
- Not checked yetcites [12]
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Studies of islet b cell compensation within models that maintain normoglycemia show upregulation of glucose metabolism pathways (12, 13, 31).”
What the sources say
- Not checked yetcites [12]
- Not checked yetcites [13]
- Not checked yetcites [31]
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“A recent study in Zucker fatty (ZF) rats has provided strong support for PKB activation in the b cell growth response to insulin resistance in this normoglycemic model (11).”
What the sources say
- Not checked yetcites [11]
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
116 more claims
Create a free account to see all 203 claims and to verify the 272 references still open.
- It may state two separate claims as one. 71
- Probably not a substantial claim. 13
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Importantly, several of these studies have demonstrated that fatty acids do not induce beta-cell dysfunction in the absence of elevated glucose, highlighting that fatty acids and glucose are not cytotoxic independently.168,169”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [169]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Notably, impairment of insulin secretion in the presence of an intact β-cell mass also occurs in the early stages of human age-related diabetes123.”
From The telomere syndromes (2012) · cites this paper as [123]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Minor deficiencies in the β-cell machinery may only be exposed in times of metabolic stress, such as pregnancy [75].”
From The Pathophysiology of Gestational Diabetes Mellitus (2018) · cites this paper as [75]
Experimental — accuracy not yet measured
Citations
Cites
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial
Chiasson, J.-L., Josse, R. G., Gomis, R., Hanefeld, M., Karasik, A., & Laakso, M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08905-5 · Cited by 2,543
Barker, D. J. P., Hales, C. N., Fall, C. H. D., Osmond, C., Phipps, K., & Clark, P. M. S. (1993) · Diabetologia · doi:10.1007/bf00399095 · Cited by 2,468
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
Grant, S. F. A., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Manolescu, A., Sainz, J., Helgason, A., Stefansson, H., Emilsson, V., Helgadottir, A., et al. (2006) · Nature Genetics · doi:10.1038/ng1732 · Cited by 2,287
The biology of incretin hormones
Drucker, D. J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.004 · Cited by 2,210
Mitochondrial dysfunction and type 2 diabetes
Lowell, B. B., & Shulman, G. I. (2005) · Science · doi:10.1126/science.1104343 · Cited by 2,070
Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase
Minokoshi, Y., Kim, Y.-B., Peroni, O. D., Fryer, L. G. D., Müller, C., Carling, D., & Kahn, B. B. (2002) · Nature · doi:10.1038/415339a · Cited by 2,053
Weyer, C., Bogardus, C., Mott, D. M., & Pratley, R. E. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7231 · Cited by 1,940
Cited by
Items 901–1,000 of 1,002
A Variant of GJD2, Encoding for Connexin 36, Alters the Function of Insulin Producing β-Cells
Cigliola, V., Populaire, C., Pierri, C. L., Deutsch, S., Haefliger, J., Fadista, J., Lyssenko, V., Groop, L., Rueedi, R., Thorel, F., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150880 · Cited by 18
“Strikingly, the pharmacological, siRNA and genetic interference with the expression and function of Cx36 results in alterations of murine β cells [16, 18, 44], which mimic the major alterations observed in T2D [45].”
BackgroundDuan, H., Lee, J. W., Moon, S. W., Arora, D. K., Li, Y., Lim, H., & Wang, W. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00041 · Cited by 20
“There are also several other β cell-protective small molecules that do not target ER stress and are not effective against ER stress, such as the STAT1 signaling inhibitor BRD0476 (N-(((2R,3R)-5-((S)-1-hydroxypropan-2-yl)-3-methyl-10-(3(naphthalen-1-yl)ureido)-6-oxo-3,4,5,6-tetrahydro-2H-benzo[b][1,5]oxazocin-2-yl)meth…”
BackgroundNrf2 in Type 2 diabetes and diabetic complications: Yin and Yang
Fu, J., Hou, Y., Xue, P., Wang, H., Xu, Y., Qu, W., Zhang, Q., & Pi, J. (2016) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2016.08.001 · Cited by 22
How does obesity lead to insulin resistance?
Choi, C. H. J., & Cohen, P. (2017) · eLife · doi:10.7554/elife.33298 · Cited by 20
Western diet given to healthy rats mimics the human phenotype of diabetic cardiomyopathy
Verboven, M., Deluyker, D., Ferferieva, V., Lambrichts, I., Hansen, D., Eijnde, B. O., & Bito, V. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.08.002 · Cited by 22
Hou, L., Tang, S., Wu, B. J., Ong, K. L., Westerterp, M., Barter, P. J., Cochran, B. J., Tabet, F., & Rye, K. (2019) · The FASEB Journal · doi:10.1096/fj.201802512rr · Cited by 24
Implications of ghrelin and hexarelin in diabetes and diabetes-associated heart diseases
Mosa, R., Zhang, Z., Shao, R., Deng, C., Chen, J., & Chen, C. (2015) · Endocrine · doi:10.1007/s12020-015-0531-z · Cited by 20
Complications of Obesity in Childhood
Gunturu, S. D., & Ten, S. (2007) · Pediatric Annals · doi:10.3928/0090-4481-20070201-08 · Cited by 21
Sfrp5 mediates glucose-induced proliferation in rat pancreatic β-cells
Guan, B., Li, W., Li, F., Xie, Y., Ni, Q., Gu, Y., Li, X., Wang, Q., Zhang, H., & Ning, G. (2016) · Journal of Endocrinology · doi:10.1530/joe-15-0535 · Cited by 19
“The failure to increase β-cell 280 proliferation may result in glucose intolerance and eventually lead to diabetes mellitus 281 (Butler et al. 2003; Prentki and Nolan 2006).”
BackgroundA Novel Pentapeptide Inhibitor Reduces Amyloid Deposit Formation by Direct Interaction with hIAPP
Shi, Y. X., Lv, W., Jiao, A., Zhang, C., & Zhang, J. (2019) · International Journal of Endocrinology · doi:10.1155/2019/9062032 · Cited by 19
“On the contrary, amyloid deposits of hIAPP contributed to the development of type 2 diabetes [15] and islet transplant failure in type 1 diabetes [13, 16].”
BackgroundKimani, C. N., Reuter, H., Kotzé, S. H., & Muller, C. J. F. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45080392 · Cited by 24
“In the context of T2D, beta-cell dysfunction, de-differentiation and apoptosis are resultant of the prevailing diabetic environment that is defined by chronic hyperglycemia, lipotoxicity, oxidative and ER stress and inflammation [198–203].”
BackgroundRoles of β-Cell Hypoxia in the Progression of Type 2 Diabetes
Yamagata, K., Tsuyama, T., & Sato, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084186 · Cited by 22
“In diabetes, pancreatic β -cells are locked in a vicious cycle, in which an impaired insulin response to glucose produces hyperglycemia, which makes β -cells more ine ffi cient at insulin secretion, and an improvement in hyperglycemia results in at least a partial recovery of β -cell function [5].”
BackgroundInfluentialMorita, S., Shimajiri, Y., Sakagashira, S., Furuta, M., & Sanke, T. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03566.x · Cited by 22
Insulin resistance or hypersecretion? The βIG picture revisited
Goel, P. (2015) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2015.07.033 · Cited by 20
Experimental models of β-cell regeneration
Bonal, C., Avril, I., & Herrera, P. L. (2008) · Biochemical Society Transactions · doi:10.1042/bst0360286 · Cited by 19
García‐Bailo, B., Karmali, M. A., Badawi, A. F., & El‐Sohemy, A. (2013) · Journal of the American College of Nutrition · doi:10.1080/07315724.2013.826112 · Cited by 20
“Sustained elevated production of insulin by the pancreas to counteract high circulating glucose may, over time, result in both insulin resistance and beta-cell dysfunction, which are major steps in the progression of type 2 diabetes [40].”
BackgroundGonzález-Alonso, A., Ramírez-Tortosa, C. L., Varela‐López, A., Roche, E., Arribas, M. I., Ramírez-Tortosa, M. C., Giampieri, F., Ochoa, J. J., & Quiles, J. L. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161023425 · Cited by 24
Xu, J., Yuan, H., Ran, T., Zhang, Y., Liu, H., Lü, S., Xiong, X., Xu, A., Jiang, Y., Lu, T., et al. (2015) · Journal of Molecular Recognition · doi:10.1002/jmr.2464 · Cited by 19
“As the need for insulin rises, the β-cells in the pancreas gradually lose the ability to produce sufficient quantities of the hormone and worsen insulin resistance, thus triggering a cycle of impaired metabolism (Kaiser et al., 2003; Prentki and Nolan, 2006).”
BackgroundThe Amplifying Pathway of the β-Cell Contributes to Diet-induced Obesity
Vetterli, L., Carobbio, S., Frigerio, F., Karaca, M., & Maechler, P. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.707448 · Cited by 20
Garbacz, W. G., Jiang, M., Xu, M., Yamauchi, J., Dong, H. H., & Xie, W. (2017) · Endocrinology · doi:10.1210/en.2017-00571 · Cited by 21
“It has been suggested that this low-grade inflammation contributes to the development of peripheral insulin resistance (3), aswell as damage to the pancreaticb cells (4).”
BackgroundThe role of orexin in controlling the activity of the adipo-pancreatic axis
Skrzypski, M., Billert, M., Nowak, K. W., & Strowski, M. Z. (2018) · Journal of Endocrinology · doi:10.1530/joe-18-0122 · Cited by 22
Jurczak, M. J., Saini, S., Ioja, S., Costa, D. K., Udeh, N., Zhao, X., Whaley, J. M., & Kibbey, R. G. (2018) · Islets · doi:10.1080/19382014.2018.1503027 · Cited by 19
Lee, Y., Shin, S., Cho, K., Kim, Y., Woo, S., Kim, H. S., Jung, S., Jo, I., Jun, H., Park, W., et al. (2019) · Cells · doi:10.3390/cells8040368 · Cited by 19
“Furthermore, the natural history of T2DM entails progressive deterioration of β-cell function, associated with loss of β-cell mass [2,3].”
BackgroundWhen does diabetes start? Early detection and intervention in type 2 diabetes mellitus
Peralta, F. G., Abreu, C., Cos, X., & Gómez‐Huelgas, R. (2020) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2019.12.004 · Cited by 26
White, S. A., Zhang, L. S., Pasula, D. J., Yang, Y. H. C., & Luciani, D. S. (2020) · Scientific Reports · doi:10.1038/s41598-020-67755-3 · Cited by 26
Quinault, A., Gausserès, B., Bailbé, D., Chebbah, N., Portha, B., Movassat, J., & Tourrel‐Cuzin, C. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.04.007 · Cited by 20
Duan, H., Arora, D. K., Yu, L., Setiadi, H., Xu, D., Lim, H., & Wang, W. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.03.057 · Cited by 19
Insulin Resistance in Congenital Adrenal Hyperplasia is Compensated for by Reduced Insulin Clearance
de Oliveira, D. M., Tura, A., Vasques, A. C. J., Camilo, D. F., Lima, M. M. D. O., de Lemos‐Marini, S. H. V., Gonçalves, E. M., Guerra‐Júnior, G., & Geloneze, B. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab010 · Cited by 18
Ethnopharmacological perspectives of glucokinase activators in the treatment of diabetes mellitus
Sharma, S., Wadhwa, K., Choudhary, M., & Budhwar, V. (2021) · Natural Product Research · doi:10.1080/14786419.2021.1931187 · Cited by 18
Gap junction coupling and islet delta-cell function in health and disease
MIRANDA, C. A., Samad, M., Vergari, E., & Briant, L. J. B. (2021) · Peptides · doi:10.1016/j.peptides.2021.170704 · Cited by 23
Effects of Red Rice Bran Extract on High-Fat Diet-Induced Obesity and Insulin Resistance in Mice
Munkong, N., Thim-uam, A., Pengnet, S., Hansakul, P., Somparn, N., Naowaboot, J., Tocharus, J., & Tocharus, C. (2022) · Preventive Nutrition and Food Science · doi:10.3746/pnf.2022.27.2.180 · Cited by 18
Peters, A., Sprengell, M., & Kubera, B. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104847 · Cited by 20
“Typical to the school of thought is the idea that “[i]n insulin-resistant states, pancreatic islets usually respond by increasing insulin secretion to maintain normoglycemia, a process termed ß-cell compensation” (Prentki and Nolan, 2006).”
Métabolisme du cholestérol et function β-cellulaire
Langhi, C., & Cariou, B. (2010) · médecine/sciences · doi:10.1051/medsci/2010264385 · Cited by 21
Gregg, B. E., Connor, C. G., Cheng, P., Ruedy, K. J., Beck, R. W., Kollman, C., Schatz, D., Cengiz, E., Tamborlane, W. V., KLINGENSMITH, G. J., et al. (2015) · Pediatric Diabetes · doi:10.1111/pedi.12280 · Cited by 18
Dong, L., Feng, R., Bi, J., Shen, S., Lu, H., & Zhang, J. (2018) · Journal of Molecular Modeling · doi:10.1007/s00894-018-3582-2 · Cited by 19
Mo, F., Liu, H., Zhang, Y., Hua, J., Zhao, D., An, T., Zhang, D., Tian, T., & Gao, S. (2019) · PubMed Central · doi:10.22038/ijbms.2019.30246.7294 · Cited by 18
“Therefore, rescuing the function of pancreatic β-cell in T2DM is crucial for the treatment of diabetes.”
BackgroundInfluentialChung, Y. W., Lee, J., Lee, J. Y., Ju, H. H., Lee, Y., Jee, D. H., Ko, S., & Choi, J. A. (2020) · American Journal Of Pathology · doi:10.1016/j.ajpath.2020.01.011 · Cited by 18
Wang, W., Jiang, H., Zhang, Z., Duan, W., Han, T., & Sun, C. (2021) · Genes & Nutrition · doi:10.1186/s12263-021-00684-6 · Cited by 21
Pancreatic Lipid Content Is Not Associated with Beta Cell Dysfunction in Youth-Onset Type 2 Diabetes
Wicklow, B. A., Griffith, A. T., Dumontet, J. N., Venugopal, N., Ryner, L. N., & McGavock, J. (2015) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2015.04.001 · Cited by 20
Development of insulin-producing cells from primitive biologic precursors
Evans-Molina, C., Vestermark, G. L., & Mirmira, R. G. (2009) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e3283186fc1 · Cited by 18
Ahangarpour, A., Oroojan, A. A., Rezae, M., Khodayar, M. J., Alboghobeish, S., & Zeinvand‐Lorestani, M. (2017) · PubMed Central · Cited by 17
Cole, L., Agarwal, P., Doucette, C. A., Fonseca, M. A., Xiang, B., Sparagna, G. C., Seshadri, N., Vandel, M., Dolinsky, V. W., & Hatch, G. M. (2021) · Endocrinology · doi:10.1210/endocr/bqab102 · Cited by 15
Okajima, Y., Matsuzaka, T., Miyazaki, S., Motomura, K., Ohno, H., Sharma, R., Shimura, T., Istiqamah, N., Han, S., Mizunoe, Y., et al. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166339 · Cited by 23
Schuurman, M., Wallace, M., Sahi, G., Barillaro, M., Zhang, S., Rahman, M. M., Sawyez, C. G., Borradaile, N. M., & Wang, R. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.938680 · Cited by 19
Chronotherapy with a glucokinase activator profoundly improves metabolism in obese Zucker rats
Kroon, T., Hagstedt, T., Alexandersson, I., FERM, A., Petersson, M., Maurer, S., Zarrouki, B., Wallenius, K., Oakes, N. D., & Boucher, J. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abh1316 · Cited by 19
An update on pancreatic regeneration mechanisms: Searching for paths to a cure for type 2 diabetes
Soldovieri, L., Giuseppe, G. D., Ciccarelli, G., Quero, G., Cinti, F., Brunetti, M., Nista, E. C., Gasbarrini, A., Alfieri, S., Pontecorvi, A., et al. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101754 · Cited by 20
“Conditions such as pregnancy and obesity are associated with a decreased sensitivity of target tissues to insulin and a consequent rise in insulin demand, initially compensated by increased b-cell function and mass [60,61].”
BackgroundQiu, J., He, S., Yu, C., Yang, R., Kuang, M., Sheng, G., & Zou, Y. (2024) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01769-0 · Cited by 20
“Additionally, older participants may already have a certain degree of IR, with compensatory increased pancreatic beta-cell function [40], which could reduce the sensitivity of METS-IR in reflecting their IR.”
BackgroundVisceral adiposity and cardiometabolic risks: epidemic of abdominal obesity in North America
Wimalawansa, S. J. (2013) · Research and Reports in Endocrine Disorders · doi:10.2147/rred.s32041 · Cited by 19
“73 However, in the presence of plentiful food availability and less physical activity, these epigenetic changes and the evolutionary survival advantage could lead to excessive fat storage, and the development of obesity and the consequent T2D.”
InfluentialVivas, Y., Martínez-García, C., Izquierdo, A., Garcia‐García, F., Callejas, S., Velasco, I., Campbell, M., Ros, M., Dopazo, A., Dopazo, J., et al. (2011) · BMC Medical Genomics · doi:10.1186/1755-8794-4-86 · Cited by 20
Protection of Human Pancreatic Islets from Lipotoxicity by Modulation of the Translocon
Cassel, R., Ducreux, S., Alam, M. R., Dingreville, F., Berlé, C., Burda-Jacob, K., Chauvin, M., Chikh, K., Païta, L., Al-Mawla, R., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148686 · Cited by 25
“Type 2 diabetes is a worldwide multifactorial disease characterized by peripheral insulin resistance and pancreatic beta cell dysfunction [1,2].”
BackgroundTestosterone Protects Pancreatic β-cells from Apoptosis and Stress-Induced Accelerated Senescence
Kang, S. M., Jung, H. S., Kwon, M. J., Lee, S. H., & Park, J. H. (2020) · The World Journal of Men s Health · doi:10.5534/wjmh.200169 · Cited by 17
“org kines, along with individual genetic susceptibility [18].”
BackgroundThe long noncoding RNA TUNAR modulates Wnt signaling and regulates human β-cell proliferation
Zhou, A., Mondal, T., Tabish, A. M., Abadpour, S., Ericson, E., Smith, D. M., Knöll, R., Scholz, H., Kanduri, C., Tyrberg, B., et al. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00335.2020 · Cited by 17
Antibodies in metabolic diseases
Ahrens, B. (2011) · New Biotechnology · doi:10.1016/j.nbt.2011.03.022 · Cited by 20
Eickhoff, H., Guimarães, A., Louro, T. M., Seiça, R. M. F., & Sousa, F. C. E. (2014) · Surgical Endoscopy · doi:10.1007/s00464-014-3675-7 · Cited by 18
“Insulin resistance and hyperinsulinemia have little influence on beta cell dysfunction [21], and the majority of patients are characterized by a compensatory augmented preoperative beta cell function [22].”
BackgroundDown-regulation of pancreatic transcription factors and incretin receptors in type 2 diabetes
Kaneto, H., & Matsuoka, T.-A. (2013) · World Journal of Diabetes · doi:10.4239/wjd.v4.i6.263 · Cited by 20
Early postnatal overnutrition accelerates aging-associated epigenetic drift in pancreatic islets
Li, G., Petkova, T. D., Laritsky, E., Kessler, N. J., Baker, M. S., Zhu, S., & Waterland, R. A. (2019) · Environmental Epigenetics · doi:10.1093/eep/dvz015 · Cited by 20
Miyawaki, K., Inoue, H., Keshavarz, P., Mizuta, K., Sato, A., Sakamoto, Y., Moritani, M., Kunika, K., Tanahashi, T., & Itakura, M. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.06.014 · Cited by 19
Abdou, H. M., El-Gendy, A. H., Aly, R. G. M., Abouzied, M. M., Eltahir, H. M., Thagfan, S. S. A., & Eweda, S. M. (2025) · Journal of Xenobiotics · doi:10.3390/jox15030064 · Cited by 16
“Another possible explanation for disrupted glucose metabolism could be the alteration in the activity of pancreatic β -cells [37].”
Lee, Y. H., & Song, G. G. (2019) · Journal of Rheumatic Diseases · doi:10.4078/jrd.2019.26.2.131 · Cited by 17
Kongthitilerd, P., Thilavech, T., Marnpae, M., Rong, W., Yao, S., Adisakwattana, S., Cheng, H., & Suantawee, T. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112494 · Cited by 18
β‐Cell glucokinase expression was increased in type 2 diabetes subjects with better glycemic control
Liu, J., Fu, H., Kang, F., Ning, G., Ni, Q., Wang, W., & Wang, Q. (2023) · Journal of Diabetes · doi:10.1111/1753-0407.13380 · Cited by 16
Xu, W., & Weng, J. (2013) · Journal of Diabetes · doi:10.1111/1753-0407.12054 · Cited by 13
BBT improves glucose homeostasis by ameliorating β-cell dysfunction in type 2 diabetic mice
Yao, X., Xu, X., Wang, G., Lei, M., Quan, L.-L., Cheng, Y., Wan, P., Zhou, J.-P., Chen, J., Hu, L., et al. (2015) · Journal of Endocrinology · doi:10.1530/joe-14-0721 · Cited by 16
“Recently, amelioration of b-cell dysfunction by activation of GSIS and/or prevention of b-cell death have been determined to be promising approaches in delaying or preventing the onset of type 2 diabetes (Rhodes 2005, Prentki & Nolan 2006, Seino et al. 2011, Rachdi et al. 2014).”
BackgroundJohnson, J. D. (2009) · Cell Cycle · doi:10.4161/cc.8.1.7343 · Cited by 19
Novel genes underlying beta cell survival in metabolic stress
Singh, H., Farouk, M., Bose, B. B., & Singh, P. (2013) · Bioinformation · doi:10.6026/97320630009037 · Cited by 18
The ABCs of β-cell dysfunction in type 2 diabetes
Chakravarthy, M. V., & Semenkovich, C. F. (2007) · Nature Medicine · doi:10.1038/nm0307-241 · Cited by 18
Evaluating insulin secretagogues in a humanized mouse model with functional human islets
Luo, J., Nguyen, K., Chen, M., TRAN, T. L., Hao, J., Tian, B., Rulifson, I. C., Zhang, Y., Tian, L., Zhang, Y., et al. (2012) · Metabolism · doi:10.1016/j.metabol.2012.07.010 · Cited by 17
Liver triacylglycerol content and gestational diabetes: effects of moderate energy restriction
Hodson, K., Dalla Man, C., Smith, F. E., Barnes, A., McParlin, C., Cobelli, C., Robson, S. C., Araújo-Soares, V., & Taylor, R. (2017) · Diabetologia · doi:10.1007/s00125-016-4143-9 · Cited by 16
Islam, S., Mir, A. R., Raghav, A., Khan, F. I., Alam, K., Ali, A., & Uddin, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169099 · Cited by 17
Oxidative and energetic stresses mediate beta-cell dysfunction induced by PGC-1α
Besseiche, A., Riveline, J., Delavallée, L., Foufelle, F., Gautier, J. F., & Blondeau, B. (2017) · Diabetes & Metabolism · doi:10.1016/j.diabet.2017.01.007 · Cited by 18
“For example, UCP2 is activated by high glucose and ROS levels, which are associated with reduced mitochondrial membrane potential and heat production [31].”
BackgroundKitao, N., Nakamura, A., Miyoshi, H., Nomoto, H., Takahashi, K., Omori, K., Yamamoto, K., Cho, K. Y., Terauchi, Y., & Atsumi, T. (2018) · Metabolism · doi:10.1016/j.metabol.2018.03.010 · Cited by 16
Zhang, L., Zhao, Y., & Guo, L. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3470 · Cited by 18
“The mechanism may be associated with disorders of mitochondrial function, oxidative stress and elevated levels of proinflammatory cytokines (3).”
Wu, J., Tao, W., Bu, D., Zhao, Y., Zhang, T., Chong, D., Xue, B., Xing, Z., & Li, C. (2019) · FEBS Letters · doi:10.1002/1873-3468.13537 · Cited by 15
Saleh, A., Anwar, M. M., Zayed, A. E.-Z., Eldeen, M. E. E., Afifi, G., Alnashiri, H. M., Gomaa, A. M. S., Abd‐Elkareem, M., Abou-Elhamd, A. S., Shaheen, E. S., et al. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s209856 · Cited by 16
“29 In the current study, diabetic rats showed a drastic decrease in acinar staining intensity re fl ecting the defect in the pancreatic digestive effect which could explain the decreased body weight of diabetic rats.”
BackgroundResultInfluentialHuman beta defensins may be a multifactorial modulator in the management of diabetic wound
Sanapalli, B. K. R., Yele, V., Kalidhindi, R. S. R., Singh, S. K., Gulati, M., & Karri, V. V. S. R. (2019) · Wound Repair and Regeneration · doi:10.1111/wrr.12785 · Cited by 17
“Diabetes mellitus (DM) arising due to the inability of the body to produce or respond to insulin has become a global threat.(1) According to the prevalence data released by the International Diabetes Federation, about 425 million people in the world were found to be affected by diabetes in 2017, and this figure is pre…”
BackgroundBombesin Receptor Subtype-3 in Human Diseases
Li, M., Peng, L., Liu, D., Yuan, F., Chen, G.-C., Zhang, L., Liu, Y., & Liu, H. (2019) · Archives of Medical Research · doi:10.1016/j.arcmed.2019.11.004 · Cited by 16
Therapeutic potential of vasoactive intestinal peptide and its receptor VPAC2 in type 2 diabetes
Hou, X., Yang, D., Yang, G., Li, M., Zhang, J., Zhang, J., Zhang, Y., & Liu, Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.984198 · Cited by 16
“Islet b-cell mass contributes to glucose homeostasis by inducing compensatory responses based on physiological requirements of insulin (43, 44).”
BackgroundNakaya, K., Kubota, N., Takamoto, I., Kubota, T., Katsuyama, H., Sato, H., Tokuyama, K., Hashimoto, S., Goto, M., Jomori, T., et al. (2013) · Metabolism · doi:10.1016/j.metabol.2013.01.010 · Cited by 16
Tushuizen, M. E., Bunck, M. C. M., Pouwels, P. J. W., Bontemps, S., Mari, A., & Diamant, M. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0424 · Cited by 17
Nagaraju, R., & Rajini, P. S. (2016) · Pesticide Biochemistry and Physiology · doi:10.1016/j.pestbp.2016.04.009 · Cited by 17
Angiopoetin-2 Signals Do Not Mediate the Hypervascularization of Islets in Type 2 Diabetes
Shah, P., Lueschen, N., Ardestani, A. D., Oberholzer, J., Olerud, J., Carlsson, P., & Maedler, K. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161834 · Cited by 18
Pdcd2l Promotes Palmitate-Induced Pancreatic Beta-Cell Apoptosis as a FoxO1 Target Gene
Yin, Y., Wei, Y. Q., Yu, J., Zhang, X., Lin, H., Zhu, Y., & Han, X. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166692 · Cited by 16
mTORC1 inhibitors rapamycin and metformin affect cardiovascular markers differentially in ZDF rats
Nistala, R., Raja, A., & Pulakat, L. (2017) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2016-0567 · Cited by 17
Teitelman, G. (2019) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155419831641 · Cited by 19
Chan, P., Liao, M.-T., Lu, C., Tian, Y., & Hsieh, P. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173703 · Cited by 15
Diabetes mellitus: interdisciplinary medical, surgical and psychological therapeutic approach
Socea, B., Silaghi, A. M., Rebegea, L. F., Bălan, D. G., Bălălău, C., Ţenea-Cojan, T. Ş., Mihai, D. A., & Păunică, I. (2023) · Journal of Mind and Medical Sciences · doi:10.22543/2392-7674.1445 · Cited by 18
SH2B1 in β-Cells Promotes Insulin Expression and Glucose Metabolism in Mice
Chen, Z., Morris, D. L., Jiang, L., Liu, Y., & Rui, L. (2014) · Molecular Endocrinology · doi:10.1210/me.2013-1333 · Cited by 15
Retinoblastoma tumor suppressor protein in pancreatic progenitors controls α- and β-cell fate
Cai, E. P., Wu, X., Schroer, S. A., Elia, A., Nostro, M. C., Zacksenhaus, E., & Woo, M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303386110 · Cited by 16
“However, this plasticity declines significantly in the postnatal period (3), resulting in a limited ability of islets to regenerate in adulthood (4).”
World Congress on Insulin Resistance, Diabetes, and Cardiovascular Disease
Bloomgarden, Z. T. (2011) · Diabetes Care · doi:10.2337/dc11-1306 · Cited by 15
Insulin secretion in health and disease: nutrients dictate the pace
Regazzi, R., Rodriguez‐Trejo, A., & Jacovetti, C. (2015) · Proceedings of The Nutrition Society · doi:10.1017/s0029665115004152 · Cited by 18
Li, C., Sun, B., Fang, Q., Ding, M., Xing, Y.-Z., Chen, L., & Yu, D. M. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00326 · Cited by 15
“Under normal circumstances, the mass of β-cell was determined by pancreas precursor cells, and maintained a dynamic equilibrium among proliferation, apoptosis, and necrosis (2).”
BackgroundBódis, K. B., KAHL, S., Simon, M., Zhou, Z., Sell, H., Knebel, B., Tura, A., Straßburger, K., Burkart, V., Müssig, K., et al. (2018) · Nutrition and Diabetes · doi:10.1038/s41387-018-0054-9 · Cited by 15
Overexpression of Gjb4 impairs cell proliferation and insulin secretion in primary islet cells
Gässler, A., Quiclet, C., Kluth, O., Gottmann, P., Schwerbel, K., Helms, A., Stadion, M., Wilhelmi, I., Jonas, W., Ouni, M., et al. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101042 · Cited by 14
Cholecystokinin attenuates β-cell apoptosis in both mouse and human islets
Kim, H. T., DESOUZA, A. H., Umhoefer, H. M., Han, J., Anzia, L. E., Sacotte, S. J., Williams, R. A., Blumer, J. T., Bartosiak, J. T., Fontaine, D. A., et al. (2021) · Translational research · doi:10.1016/j.trsl.2021.10.005 · Cited by 17
Wu, N., Jin, W., Zhao, Y., Wang, H., He, S., Zhang, W., & Zhou, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.881256 · Cited by 21
“A recent study revealed two exocytosis modes: (1) full fusion, in which the exocytic vesicle and the plasma membrane fusion completely; and (2) kiss‐and‐run events, in which insulin granules release their contents through a transiently opened fusion pore (25).”
BackgroundMethodEndoplasmic reticulum as a therapeutic target in type 2 diabetes: Role of phytochemicals
Sajadimajd, S., Deravi, N., Forouhar, K., Rahimi, R., Kheirandish, A., & Bahramsoltani, R. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109508 · Cited by 16
DeBoer, M. D., & Gurka, M. J. (2014) · Cardiovascular Diabetology · doi:10.1186/1475-2840-13-83 · Cited by 16
Singh, A. K., & Singh, R. (2016) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.176353 · Cited by 18
“Unfortunately, due to the progressive loss of β‐cell function and possibly β‐cell mass, many patients eventually fail to achieve target hemoglobin A1c (HbA1c) level, despite using multiple agents.[3] Moreover, conventional secretagogues such as sulfonylureas are associated with hypoglycemia and weight gain that act as…”
BackgroundMedicinal Chemistry of Glucagon-Like Peptide Receptor Agonists
Jones, L. H., & Price, D. A. (2013) · Progress in medicinal chemistry · doi:10.1016/b978-0-444-62652-3.00002-8 · Cited by 19
Real time imaging of intracellular hydrogen peroxide in pancreatic islets
Neal, A., Rountree, A. M., Kernan, K. A., van Yserloo, B., Zhang, H.-L., Reed, B. J., Osborne, W., Wang, W., & Sweet, I. (2016) · Biochemical Journal · doi:10.1042/bcj20160481 · Cited by 14
“Importance of H2O2 in islets Failure of pancreatic β cells to compensate for increased insulin resistance is a major determinant of diabetes [1, 2].”
Background
Metadata
- Authors
- Prentki, M.
- Affiliations
- Centre Hospitalier de l’Université de Montréal (CA)
- Corresponding author
- Prentki, M.
- ORCID
- Prentki, M.
- Venue
- Journal of Clinical Investigation
- Published
- 2006-07-03
- Volume
- 116
- Issue
- 7
- Pages
- 1802-1812
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1483155
- OpenAlex
- W1598254642
- Cited by
- 1,690
- References
- 132
- Citations by year
- 2026: 52 · 2025: 52 · 2024: 46 · 2023: 54 · 2022: 68 · 2021: 95 · 2020: 95 · 2019: 111 · 2018: 90 · 2017: 109 · 2016: 112 · 2015: 107 · 2014: 131 · 2013: 97 · 2012: 98
- FWCI
- 13.11
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- ANU Open Research (Australian National University) (submittedVersion)
- Funders
- ACT Government
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK063356, DK63356)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- beta-cell failure, type 2 diabetes, obesity, beta-cell compensation, beta-cell mass expansion, insulin resistance, genetic susceptibility, intrauterine factors, environmental risk factors, beta-cell dysfunction
- MeSH terms
- Animals, Diabetes Mellitus, Type 2, Humans, Insulin Resistance, Disease Progression, Genetic Predisposition to Disease, Insulin-Secreting Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.